المؤلفون: Valenza, Carmine, De Pas, Tommaso Martino, Gaeta, Aurora, Castellano, Grazia, Santoro, Celeste, Corona, Amedeo, Chiappini, Giulia, Vivanet, Grazia, Trapani, Dario, Coppola, Sara, Conforti, Fabio, Mattar, Denise, Gandini, Sara, Veronesi, Paolo, Pennacchioli, Elisabetta, Curigliano, Giuseppe

المصدر: In European Journal of Cancer January 2024 196

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Kotteas, Elias, Bielo, Luca Boscolo, Valenza, Carmine, Santoro, Celeste, Koukoutzeli, Chrysanthi, Trapani, Dario, Curigliano, Giuseppe

المصدر: Expert Review of Anticancer Therapy; 2023, Vol. 23 Issue 10, p1107-1116, 10p

مصطلحات موضوعية: TRIPLE-negative breast cancer, NEOADJUVANT chemotherapy

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Katrini, Jalissa, Scafetta, Roberta, Boldrini, Laura, Ascione, Liliana, Santoro, Celeste, Guidi, Lorenzo, Valenza, Carmine, Trapani, Dario, Curigliano, Giuseppe

المصدر: In Reference Module in Life Sciences 2017

المؤلفون: Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Belli C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Crimini E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Repetto M; Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, USA., Ascione L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Pellizzari G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Santoro C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Fuorivia V; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Rocco EG; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

المصدر: The oncologist [Oncologist] 2024 Jun 03; Vol. 29 (6), pp. 504-510.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Unknown Primary*/genetics , Neoplasms, Unknown Primary*/drug therapy , Neoplasms, Unknown Primary*/pathology , Genomics*/methods, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; High-Throughput Nucleotide Sequencing/methods ; Adult ; Aged, 80 and over ; Mutation ; Europe